Apollomics
APLM
NASDAQ
IPO2023
about APLM
Apollomics is a biopharmaceutical company focused on developing innovative cancer therapies, including antibody-drug conjugates and bispecific antibodies for targeted cancer immunotherapies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.94 | $9.95 | $6.94 | $14.64M | 185.36K |